The Molecular Tumor Board Turns 10: The Age of Complexity.

IF 4.8 2区医学 Q1 ONCOLOGY

Oncologist Pub Date : 2025-03-10 DOI:10.1093/oncolo/oyae271

Adam Wahida, Razelle Kurzrock

引用次数: 0

Abstract

Gene sequencing has brought a titanic of complex data into clinical precision oncology. Deciphering this complexity for practice requires new constructs. In 2014, the Molecular Tumor Board (MTB) was introduced into the literature by a publication in The Oncologist. Ten years later, MTBs have become globally established vehicles that integrate rapidly emerging "omic" information, helping to transform cancer management.

查看原文本刊更多论文

分子肿瘤委员会十周年：复杂性时代。

基因测序为临床精准肿瘤学带来了大量复杂的数据。为实践破译这些复杂数据需要新的构架。2014 年，《肿瘤学家》（The Oncologist）上发表的一篇文章将分子肿瘤委员会（MTB）引入文献。十年后，MTB 已成为全球公认的工具，整合了快速涌现的 "奥米克 "信息，帮助改变癌症管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncologist 医学-肿瘤学

CiteScore

10.40

自引率

3.40%

发文量

309

审稿时长

3-8 weeks

期刊介绍： The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.